Biogen Inc. (BIIB)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for BIIB is $238.98, 2.7% above the last close of $232.65 on Oct 16, 2026; targets range from $178.90 to $302.56. Rating consensus: Buy.
Snapshot
- P/E41.2x
- P/E vs sector+46.3%
- P/E vs own+81.9%
- Target upside+2.7%
- ConsensusBuy
- Market cap$34.37B
- FCF yield+8.6%
- Insiders-$240K
- Earnings in12d
- News
Why it moved
Biogen Inc. (BIIB) fell 1.1% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
1 story on the day (30-day average 0.5).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $232.65 · +63.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI61
- Support-2.6%
- Resistance—
- Off 52w high-1.1%
- Off ATH-51.1%
- 52w range$232.65
- Bollingerupper half
- MACD0.78
- ATR+2.7%
- Volume1.2x
Analyst price targets
22 firms with a target in the last 12 months · last close $232.65 · as of Oct 16, 2026
Strong buy 4 · Buy 20 · Hold 12 · Sell 1 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +3.4% year over year, free cash flow 17.9% of revenue, operating margin 11.6%.
| Q2 FY2026 | Jun 30, 2026 | $2.74B | 0.66 | $490M | 56.9% | 11.6% | 3.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.48B | 2.15 | $697M | 73.3% | 16.0% | 12.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.28B | -0.33 | $556M | 78.2% | -2.5% | -2.1% |
| Q3 FY2025 | Sep 30, 2025 | $2.45B | 3.17 | $1.23B | 64.3% | 25.0% | 19.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.65B | 4.35 | $144M | 64.2% | 22.2% | 24.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.43B | 1.64 | $212M | 76.2% | 30.1% | 9.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.45B | 1.83 | $695M | 76.2% | 20.7% | 10.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.47B | 2.66 | $806M | 74.1% | 23.4% | 15.8% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $255.56 | +0.9% | -8.2% | +8.8% | 38.7 | $616B | |
| 2 |  | $285.42 | +0.7% | 0.0% | -1.4% | 80.4 | $504B | |
| 3 |  | $145.95 | +0.5% | -6.2% | +7.7% | 116.8 | $360B | |
| 4 |  | $432.49 | -0.4% | -2.6% | -7.5% | 26.9 | $234B | |
| 5 |  | $156.19 | -0.7% | -0.7% | +1.9% | — | $194B | |
| 6 |  | $29.58 | +0.5% | 0.0% | -7.1% | 39.1 | $169B | |
| 7 |  | $59.75 | -1.4% | -11.3% | +9.4% | 13.2 | $122B | |
| 8 | | $232.65 | -1.1% | -1.1% | +2.7% | 41.2 | $34.37B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.